Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer

Abstract Mutation of the adenomatous polyposis coli ( APC ) tumor suppressor gene initiates the majority of colorectal (CR) cancers. One consequence of this inactivation is constitutive activation of β-catenin/Tcf-mediated transcription. To further explore the role of the APC/β-catenin/Tcf pathway in CR tumorigenesis, we searched for mutations in genes implicated in this pathway in CR tumors lacking APC mutations. No mutations of the γ-catenin ( CTNNG1 ), GSK-3α ( GSK3A ), or GSK-3β ( GSK3B ) genes were detected. In contrast, mutations in the NH 2 -terminal regulatory domain of β-catenin ( CTNNB1 ) were found in 13 of 27 (48%) CR tumors lacking APC mutations. Mutations in the β-catenin regulatory domain and APC were observed to be mutually exclusive, consistent with their equivalent effects on β-catenin stability and Tcf transactivation. In addition, we found that CTNNB1 mutations can occur in the early, adenomatous stage of CR neoplasia, as has been observed previously with APC mutations. These results suggest that CTNNB1 mutations can uniquely substitute for APC mutations in CR tumors and that β-catenin signaling plays a critical role in CR tumorigenesis.

[1]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[2]  M W Klymkowsky,et al.  Anterior axis duplication in Xenopus induced by the over-expression of the cadherin-binding protein plakoglobin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[4]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[5]  P. Soballe,et al.  Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. , 1997, Cancer research.

[6]  J. D. den Dunnen,et al.  Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. , 1994, Genomics.

[7]  P. Polakis,et al.  The APC Protein and E-cadherin Form Similar but Independent Complexes with α-Catenin, β-Catenin, and Plakoglobin (*) , 1995, The Journal of Biological Chemistry.

[8]  B. Herrmann,et al.  Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.

[9]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[10]  K. Kinzler,et al.  The APC gene product in normal and tumor cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Moon,et al.  The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. , 1996, Genes & development.

[12]  Stephen W. Byers,et al.  Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin* , 1997, The Journal of Biological Chemistry.

[13]  M. Peifer.  Regulating Cell Proliferation--As Easy as APC , 1996, Science.

[14]  Margaret J. Wheelock,et al.  Identification of Plakoglobin Domains Required for Association with N-cadherin and α-Catenin (*) , 1995, The Journal of Biological Chemistry.

[15]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[16]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[17]  R. Brent,et al.  APC binds to the novel protein EB1. , 1995, Cancer research.

[18]  T. Akiyama,et al.  Binding of APC to the Human Homolog of the Drosophila Discs Large Tumor Suppressor Protein , 1996, Science.

[19]  K. Kinzler,et al.  Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. , 1995, Cancer research.

[20]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Polakis,et al.  Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein , 1996, Molecular and cellular biology.

[22]  W. Birchmeier,et al.  E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton , 1994, The Journal of cell biology.